Opportunity for Baxter Investors to Lead Class Action
In a significant development for investors of Baxter International, Inc. (NYSE: BAX), a firm has stepped forward to announce that those who have experienced substantial financial losses have an opportunity to lead a class action lawsuit. This announcement comes from a prominent law firm that specializes in securities litigation.
Details of the Class Action Lawsuit
Investors who purchased Baxter common stock between February 23, 2022 and July 30, 2025, are invited to step forward. The class action, titled Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., targets Baxter and select executives for alleged violations of the Securities Exchange Act of 1934. Those affected must act swiftly, as the deadline to seek lead plaintiff status is set for December 15, 2025.
Allegations Against Baxter
The class action lawsuit alleges a series of serious claims against Baxter, citing that the company’s Novum IQ Large Volume Pump faced systemic defects leading to significant malfunctions. These issues reportedly caused both overinfusion and underinfusion of fluids, presenting a potential risk to patient health, including serious injuries or death.
According to the lawsuit, Baxter was made aware of numerous malfunctions and resultant injuries but failed to implement adequate remedies. Despite customer alerts, fundamental design flaws persisted, jeopardizing patient safety. As these issues became public, it was reported that Baxter had to halt shipments and installations of its Novum LVP due to these ongoing problems.
Impact on Baxter's Stock
The resulting publicity and acknowledgment of these issues led to a significant drop in Baxter’s stock value, plunging over 22% in a short time following the disclosure. Investors who suffered losses due to these market fluctuations now have the chance to represent their interests in the forthcoming class action litigation.
Becoming a Lead Plaintiff
The Private Securities Litigation Reform Act of 1995 facilitates the process for investors keen to be appointed as lead plaintiffs. This position is generally held by the investor with the greatest financial stake in the case, who can represent all other class members. Notably, joining as a lead plaintiff is not necessary to share in any future recoveries that may result from the class action.
Robbins Geller Rudman & Dowd LLP's Role
The law firm handling this case, Robbins Geller Rudman & Dowd LLP, has earned a reputation as a top-tier firm in investor representation against securities fraud. Having secured significant monetary relief for investors over the years, they have been recognized among the best in the sector.
Contact Information for Interested Investors
If you believe you qualify as a lead plaintiff or simply wish to learn more about the case, you can reach out to attorneys at Robbins Geller Rudman & Dowd LLP. Legal experts J.C. Sanchez and Jennifer N. Caringal are available for consultations to assist potential claimants.
Robbins Geller's office can be found at 655 W. Broadway, Suite 1900, located in San Diego. You can connect with them by calling 800-449-4900 for further assistance.
Frequently Asked Questions
What is the class action lawsuit against Baxter about?
The lawsuit addresses allegations that Baxter's Novum IQ Large Volume Pump had systemic defects causing severe malfunctions, risking patient safety.
Who can participate in the class action?
Investors who purchased Baxter's common stock within the specified class period and suffered losses are eligible to seek lead plaintiff status.
What is the deadline to become a lead plaintiff?
The deadline for investors to act and seek lead plaintiff status is December 15, 2025.
What should I do if I want to join the lawsuit?
Interested investors should contact the law firm Robbins Geller Rudman & Dowd LLP for guidance and next steps regarding participation.
How does one become a lead plaintiff?
The lead plaintiff role is generally assigned to the investor with the highest financial interest in the outcome and who can adequately represent the class.
